Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-28T14:22:09.717Z Has data issue: false hasContentIssue false
  • English
  • Français

The current state of play on the molecular genetics of depression

Published online by Cambridge University Press:  12 June 2012

S. Cohen-Woods ,
I. W. Craig  and
P. McGuffin
S. Cohen-Woods*
Affiliation:
MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, UK
I. W. Craig
Affiliation:
MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, UK
P. McGuffin
Affiliation:
MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, UK
*
*Address for correspondence: Dr S. Cohen-Woods, Institute of Psychiatry, Box PO80, De Crespigny Park, London SE5 8AF, UK. (Email: [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

It has been well established that both genes and non-shared environment contribute substantially to the underlying aetiology of major depressive disorder (MDD). A comprehensive overview of genetic research in MDD is presented.

Method

Papers were retrieved from PubMed up to December 2011, using many keywords including: depression, major depressive disorder, genetics, rare variants, gene–environment, whole genome, epigenetics, and specific candidate genes and variants. These were combined in a variety of permutations.

Results

Linkage studies have yielded some promising chromosomal regions in MDD. However, there is a continued lack of consistency in association studies, in both candidate gene and genome-wide association studies (GWAS). Numerous factors may account for variable results including the use of different diagnostic approaches, small samples in early studies, population stratification, epigenetic phenomena, copy number variation (CNV), rare variation, and phenotypic and allelic heterogeneity. The conflicting results are also probably, in part, a consequence of environmental factors not being considered or controlled for.

Conclusions

Each research group has to identify what issues their sample may best address. We suggest that, where possible, more emphasis should be placed on the environment in molecular behavioural genetics to identify individuals at environmental high risk in addition to genetic high risk. Sequencing should be used to identify rare and alternative variation that may act as a risk factor, and a systems biology approach including gene–gene interactions and pathway analyses would be advantageous. GWAS may require even larger samples with reliably defined (sub)phenotypes.

Keywords

Depressionepigeneticsgene–environmentgeneticsGWAS
Type
Review Article
Information
Psychological Medicine , Volume 43 , Issue 4 , April 2013 , pp. 673 - 687
Copyright
Copyright © Cambridge University Press 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abkevich, V, Camp, NJ, Hensel, CH, Neff, CD, Russell, DL, Hughes, DC, Plenk, AM, Lowry, MR, Richards, RL, Carter, C, Frech, GC, Stone, S, Rowe, K, Chau, CA, Cortado, K, Hunt, A, Luce, K, O'Neil, G, Poarch, J, Potter, J, Poulsen, GH, Saxton, H, Bernat-Sestak, M, Thompson, V, Gutin, A, Skolnick, MH, Shattuck, D, Cannon-Albright, L (2003). Predisposition locus for major depression at chromosome 12q22-12q23.2. American Journal of Human Genetics 73, 1271–1281.CrossRefGoogle Scholar
Anguelova, M, Benkelfat, C, Turecki, G (2003). A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Molecular Psychiatry 8, 646–653.CrossRefGoogle ScholarPubMed
Battersby, S, Ogilvie, AD, Smith, CA, Blackwood, DH, Muir, WJ, Quinn, JP, Fink, G, Goodwin, GM, Harmar, AJ (1996). Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder. Psychiatric Genetics 6, 177–181.CrossRefGoogle ScholarPubMed
Baune, BT, Hohoff, C, Mortensen, LS, Deckert, J, Arolt, V, Domschke, K (2008). Serotonin transporter polymorphism (5-HTTLPR) association with melancholic depression: a female specific effect? Depression and Anxiety 25, 920–925.CrossRefGoogle ScholarPubMed
Bonvicini, C, Minelli, A, Scassellati, C, Bortolomasi, M, Segala, M, Sartori, R, Giacopuzzi, M, Gennarelli, M (2010). Serotonin transporter gene polymorphisms and treatment-resistant depression. Progress in Neuropsychopharmacology and Biological Psychiatry 34, 934–939.CrossRefGoogle ScholarPubMed
Bozina, N, Mihaljevic-Peles, A, Sagud, M, Jakovljevic, M, Sertic, J (2006). Serotonin transporter polymorphism in Croatian patients with major depressive disorder. Psychiatria Danubina 18, 83–89.Google ScholarPubMed
Breen, G, Webb, BT, Butler, A, van den Oord, EJ, Tozzi, F, Craddock, N, Gill, M, Korszun, A, Maier, W, Middleton, L, Holsboer, F, Mors, O, Lucae, S, Owen, MJ, Cohen Woods, S, Perry, J, Galwey, NW, Upmanyu, R, Craig, I, Lewis, C, Ng, M, Brewster, S, Preisig, M, Rietschel, M, Jones, L, Knight, J, Rice, J, Muglia, P, Farmer, AE, McGuffin, P (2011). A genomewide significant linkage for severe depression on chromosome 3: the Depression Network Study. Journal of Psychiatry 168, 840–847.Google ScholarPubMed
Brown, GW (2012). The promoter of the serotonin transporter genotype, environment and depression: a hypothesis supported? Journal of Affective Disorders 137, 1–3.CrossRefGoogle ScholarPubMed
Brummett, BH, Krystal, AD, Siegler, IC, Kuhn, C, Surwit, RS, Zuchner, S, Ashley-Koch, A, Barefoot, JC, Williams, RB (2007). Associations of a regulatory polymorphism of monoamine oxidase-A gene promoter (MAOA-uVNTR) with symptoms of depression and sleep quality. Psychosomatic Medicine 69, 396–401.CrossRefGoogle ScholarPubMed
Burcescu, I, Wigg, K, Gomez, L, King, N, Vetro, A, Kiss, E, Kapornai, K, Gadoros, J, Kennedy, JL, Kovacs, M, Barr, CL (2006). Association study of the adrenergic receptors and childhood-onset mood disorders in Hungarian families. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 141, 227–233.CrossRefGoogle Scholar
Camp, NJ, Lowry, MR, Richards, RL, Plenk, AM, Carter, C, Hensel, CH, Abkevich, V, Skolnick, MH, Shattuck, D, Rowe, KG, Hughes, DC, Cannon-Albright, LA (2005). Genome-wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent, early-onset major depression and anxiety disorders. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics 135B, 85–93.CrossRefGoogle ScholarPubMed
Caspi, A, Sugden, K, Moffitt, TE, Taylor, A, Craig, IW, Harrington, H, McClay, J, Mill, J, Martin, J, Braithwaite, A, Poulton, R (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386–389.CrossRefGoogle ScholarPubMed
Charney, DS, Manji, HK (2004). Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Science Signaling 2004, re5.Google ScholarPubMed
Christiansen, L, Tan, Q, Iachina, M, Bathum, L, Kruse, TA, McGue, M, Christensen, K (2007). Candidate gene polymorphisms in the serotonergic pathway: influence on depression symptomatology in an elderly population. Biological Psychiatry 61, 223–230.CrossRefGoogle Scholar
Collier, DA, Stober, G, Li, T, Heils, A, Catalano, M, Di Bella, D, Arranz, MJ, Murray, RM, Vallada, HP, Bengel, D, Muller, CR, Roberts, GW, Smeraldi, E, Kirov, G, Sham, P, Lesch, KP (1996). A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Molecular Psychiatry 1, 453–460.Google ScholarPubMed
Cowen, PJ, Charig, EM (1987). Neuroendocrine responses to intravenous tryptophan in major depression. Archives of General Psychiatry 44, 958–966.CrossRefGoogle ScholarPubMed
Craig, SP, Boularand, S, Darmon, MC, Mallet, J, Craig, IW (1991). Localization of human tryptophan hydroxylase (TPH) to chromosome 11p15.3-p14 by in situ hybridization. Cytogenetics and Cell Genetics 56, 157–159.CrossRefGoogle ScholarPubMed
Davies, PA, Pistis, M, Hanna, MC, Peters, JA, Lambert, JJ, Hales, TG, Kirkness, EF (1999). The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature 397, 359–363.CrossRefGoogle Scholar
Dikeos, DG, Papadimitriou, GN, Avramopoulos, D, Karadima, G, Daskalopoulou, EG, Souery, D, Mendlewicz, J, Vassilopoulos, D, Stefanis, CN (1999). Association between the dopamine D3 receptor gene locus (DRD3) and unipolar affective disorder. Psychiatric Genetics 9, 189–195.CrossRefGoogle ScholarPubMed
Dong, C, Wong, ML, Licinio, J (2009). Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans. Molecular Psychiatry 14, 1105–1118.CrossRefGoogle ScholarPubMed
Duman, RS (1999). The neurochemistry of mood disorders: preclinical studies. In Neurobiology of Mental Illness(ed. Charney, D. S., Nestler, E. J. and Bunney, B. S.), pp. 333–347. Oxford University Press: New York.Google Scholar
Eley, TC, Deater-Deckard, K, Fombonne, E, Fulker, DW, Plomin, R (1998). An adoption study of depressive symptoms in middle childhood. Journal of Child Psychology and Psychiatry 39, 337–345.CrossRefGoogle ScholarPubMed
Eley, TC, Sugden, K, Corsico, A, Gregory, AM, Sham, P, McGuffin, P, Plomin, R, Craig, IW (2004). Gene-environment interaction analysis of serotonin system markers with adolescent depression. Molecular Psychiatry 9, 908–915.CrossRefGoogle ScholarPubMed
Fergusson, DM, Horwood, LJ, Miller, AL, Kennedy, MA (2012). Life stress, 5-HTTLPR and mental disorder: findings from a 30-year longitudinal study. British Journal of Psychiatry 198, 129–135.CrossRefGoogle Scholar
Fisher, H, Cohen-Woods, S, Hosang, G, Korszun, A, Owen, M, Craddock, N, Craig, IW, Farmer, AE, McGuffin, P, Uher, R (in press). Interaction between specific forms of childhood maltreatment and the serotonin transporter gene (5-HTT) in recurrent depressive disorder. Journal of Affective Disorders.Google Scholar
Fisher, HL, Cohen-Woods, S, Hosang, GM, Uher, R, Powell-Smith, G, Keers, R, Tropeano, M, Korszun, A, Jones, L, Jones, I, Owen, M, Craddock, N, Craig, IW, Farmer, AE, McGuffin, P (2012). Stressful life events and the serotonin transporter gene (5-HTT) in recurrent clinical depression. Journal of Affective Disorders 136, 189–193.CrossRefGoogle ScholarPubMed
Frisch, A, Postilnick, D, Rockah, R, Michaelovsky, E, Postilnick, S, Birman, E, Laor, N, Rauchverger, B, Kreinin, A, Poyurovsky, M, Schneidman, M, Modai, I, Weizman, R (1999). Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways. Molecular Psychiatry 4, 389–392.CrossRefGoogle ScholarPubMed
Fuchs, E, Flugge, G (2003). Chronic social stress: effects on limbic brain structures. Physiology and Behavior 79, 417–427.CrossRefGoogle ScholarPubMed
Furlong, RA, Coleman, TA, Ho, L, Rubinsztein, JS, Walsh, C, Paykel, ES, Rubinsztein, DC (1998 a). No association of a functional polymorphism in the dopamine D2 receptor promoter region with bipolar or unipolar affective disorders. American Journal of Medical Genetics 81, 385–387.3.0.CO;2-S>CrossRefGoogle ScholarPubMed
Furlong, RA, Ho, L, Walsh, C, Rubinsztein, JS, Jain, S, Paykel, ES, Easton, DF, Rubinsztein, DC (1998 b). Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. American Journal of Medical Genetics 81, 58–63.3.0.CO;2-V>CrossRefGoogle ScholarPubMed
Garriock, HA, Delgado, P, Kling, MA, Carpenter, LL, Burke, M, Burke, WJ, Schwartz, T, Marangell, LB, Husain, M, Erickson, RP, Moreno, FA (2006). Number of risk genotypes is a risk factor for major depressive disorder: a case control study. Behavioral and Brain Functions 2, 24.CrossRefGoogle ScholarPubMed
Gizatullin, R, Zaboli, G, Jonsson, EG, Asberg, M, Leopardi, R (2006). Haplotype analysis reveals tryptophan hydroxylase (TPH) 1 gene variants associated with major depression. Biological Psychiatry 59, 295–300.CrossRefGoogle ScholarPubMed
Glatt, CE, Carlson, E, Taylor, TR, Risch, N, Reus, VI, Schaefer, CA (2005). Response to Zhang et al. (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11–16. Neuron 48, 704–705.CrossRefGoogle Scholar
Glessner, JT, Wang, K, Sleiman, PM, Zhang, H, Kim, CE, Flory, JH, Bradfield, JP, Imielinski, M, Frackleton, EC, Qiu, H, Mentch, F, Grant, SF, Hakonarson, H (2010). Duplication of the SLIT3 locus on 5q35.1 predisposes to major depressive disorder. PLoS ONE 5, e15463.CrossRefGoogle ScholarPubMed
Gratacos, M, Gonzalez, JR, Mercader, JM, de Cid, R, Urretavizcaya, M, Estivill, X (2007). Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biological Psychiatry 61, 911–922.CrossRefGoogle ScholarPubMed
Gutierrez, B, Arias, B, Gasto, C, Catalan, R, Papiol, S, Pintor, L, Fananas, L (2004). Association analysis between a functional polymorphism in the monoamine oxidase A gene promoter and severe mood disorders. Psychiatric Genetics 14, 203–208.CrossRefGoogle ScholarPubMed
Hanson, IM, Seawright, A, van Heyningen, V (1992). The human BDNF gene maps between FSHB and HVBS1 at the boundary of 11p13-p14. Genomics 13, 1331–1333.CrossRefGoogle ScholarPubMed
Harrington, R, Rutter, M, Weissman, M, Fudge, H, Groothues, C, Bredenkamp, D, Pickles, A, Rende, R, Wickramaratne, P (1997). Psychiatric disorders in the relatives of depressed probands. I. Comparison of prepubertal, adolescent and early adult onset cases. Journal of Affective Disorders 42, 9–22.CrossRefGoogle ScholarPubMed
Hauser, J, Leszczynska, A, Samochowiec, J, Czerski, PM, Ostapowicz, A, Chlopocka, M, Horodnicki, J, Rybakowski, JK (2003). Association analysis of the insertion/deletion polymorphism in serotonin transporter gene in patients with affective disorder. European Psychiatry 18, 129–132.CrossRefGoogle ScholarPubMed
Heils, A, Teufel, A, Petri, S, Stober, G, Riederer, P, Bengel, D, Lesch, KP (1996). Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry 66, 2621–2624.CrossRefGoogle ScholarPubMed
Hek, K, Mulder, CL, Luijendijk, HJ, van Duijn, CM, Hofman, A, Uitterlinden, AG, Tiemeier, H (2010). The PCLO gene and depressive disorders: replication in a population-based study. Human Molecular Genetics 19, 731–734.CrossRefGoogle ScholarPubMed
Holmans, P, Weissman, MM, Zubenko, GS, Scheftner, WA, Crowe, RR, DePaulo, Jr. JR, Knowles, JA, Zubenko, WN, Murphy-Eberenz, K, Marta, DH, Boutelle, S, McInnis, MG, Adams, P, Gladis, M, Steele, J, Miller, EB, Potash, JB, Mackinnon, DF, Levinson, DF (2007). Genetics of recurrent early-onset major depression (GenRED): final genome scan report. American Journal of Psychiatry 164, 248–258.CrossRefGoogle ScholarPubMed
Holmans, P, Zubenko, GS, Crowe, RR, DePaulo, Jr. JR, Scheftner, WA, Weissman, MM, Zubenko, WN, Boutelle, S, Murphy-Eberenz, K, MacKinnon, D, McInnis, MG, Marta, DH, Adams, P, Knowles, JA, Gladis, M, Thomas, J, Chellis, J, Miller, E, Levinson, DF (2004). Genomewide significant linkage to recurrent, early-onset major depressive disorder on chromosome 15q. American Journal of Human Genetics 74, 1154–1167.CrossRefGoogle ScholarPubMed
Huang, YY, Oquendo, MA, Friedman, JM, Greenhill, LL, Brodsky, B, Malone, KM, Khait, V, Mann, JJ (2003). Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism. Neuropsychopharmacology 28, 163–169.CrossRefGoogle ScholarPubMed
Inoue, K, Itoh, K, Yoshida, K, Higuchi, H, Kamata, M, Takahashi, H, Shimizu, T, Suzuki, T (2007). No association of the G1287A polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese population. Biological and Pharmaceutical Bulletin 30, 1996–1998.CrossRefGoogle Scholar
Inoue, K, Itoh, K, Yoshida, K, Shimizu, T, Suzuki, T (2004). Positive association between T-182C polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese population. Neuropsychobiology 50, 301–304.CrossRefGoogle Scholar
International Schizophrenia Consortium (2008). Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455, 237–241.CrossRefGoogle Scholar
Kaiser, R, Tremblay, PB, Schmider, J, Henneken, M, Dettling, M, Muller-Oerlinghausen, B, Uebelhack, R, Roots, I, Brockmoller, J (2001). Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia. Molecular Psychiatry 6, 179–185.CrossRefGoogle ScholarPubMed
Kao, CF, Jia, P, Zhao, Z, Kuo, PH (2012). Enriched pathways for majore depressive disorder identified from a genome-wide association study. International Journal of Neuropsychopharmacology 16, 1–11.Google Scholar
Karg, K, Burmeister, M, Shedden, K, Sen, S (2011). The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Archives of General Psychiatry 68, 444–454.CrossRefGoogle ScholarPubMed
Kendler, KS (1996). Major depression and generalised anxiety disorder. Same genes, (partly)different environments – revisited. British Journal of Psychiatry 168 (Suppl. 30), 68–75.CrossRefGoogle Scholar
Kendler, KS, Karkowski, LM, Prescott, CA (1999). Causal relationship between stressful life events and the onset of major depression. American Journal of Psychiatry 156, 837–841.CrossRefGoogle ScholarPubMed
Kendler, KS, Neale, MC, Kessler, RC, Heath, AC, Eaves, LJ (1993). The lifetime history of major depression in women. Reliability of diagnosis and heritability. Archives of General Psychiatry 50, 863–870.CrossRefGoogle ScholarPubMed
Kessler, R, McGonagle, K, Zhao, S, Nelson, C, Hughes, M, Eshleman, S, Wittchen, H, Kendler, K (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry 51, 8–19.CrossRefGoogle ScholarPubMed
Klimek, V, Stockmeier, C, Overholser, J, Meltzer, HY, Kalka, S, Dilley, G, Ordway, GA (1997). Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. Journal of Neuroscience 17, 8451–8458.CrossRefGoogle ScholarPubMed
Koks, S, Nikopensius, T, Koido, K, Maron, E, Altmae, S, Heinaste, E, Vabrit, K, Tammekivi, V, Hallast, P, Kurg, A, Shlik, J, Vasar, V, Metspalu, A, Vasar, E (2006). Analysis of SNP profiles in patients with major depressive disorder. International Journal of Neuropsychopharmacology 9, 167–174.CrossRefGoogle ScholarPubMed
Kunugi, H, Ishida, S, Kato, T, Tatsumi, M, Sakai, T, Hattori, M, Hirose, T, Nanko, S (1999). A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders. Molecular Psychiatry 4, 393–395.CrossRefGoogle ScholarPubMed
Kunugi, H, Vallada, HP, Hoda, F, Kirov, G, Gill, M, Aitchison, KJ, Ball, D, Arranz, MJ, Murray, RM, Collier, DA (1997). No evidence for an association of affective disorders with high- or low-activity allele of catechol-o-methyltransferase gene. Biological Psychiatry 42, 282–285.CrossRefGoogle ScholarPubMed
Lappalainen, J, Zhang, L, Dean, M, Oz, M, Ozaki, N, Yu, DH, Virkkunen, M, Weight, F, Linnoila, M, Goldman, D (1995). Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C). Genomics 27, 274–279.CrossRefGoogle ScholarPubMed
Lerer, B, Macciardi, F, Segman, RH, Adolfsson, R, Blackwood, D, Blairy, S, Del Favero, J, Dikeos, DG, Kaneva, R, Lilli, R, Massat, I, Milanova, V, Muir, W, Noethen, M, Oruc, L, Petrova, T, Papadimitriou, GN, Rietschel, M, Serretti, A, Souery, D, Van Gestel, S, Van Broeckhoven, C, Mendlewicz, J (2001). Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Molecular Psychiatry 6, 579–585.CrossRefGoogle ScholarPubMed
Lesch, KP, Bengel, D, Heils, A, Sabol, SZ, Greenberg, BD, Petri, S, Benjamin, J, Muller, CR, Hamer, DH, Murphy, DL (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527–1531.CrossRefGoogle ScholarPubMed
Levinson, DF, Evgrafov, OV, Knowles, JA, Potash, JB, Weissman, MM, Scheftner, WA, DePaulo, Jr. JR, Crowe, RR, Murphy-Eberenz, K, Marta, DH, McInnis, MG, Adams, P, Gladis, M, Miller, EB, Thomas, J, Holmans, P (2007). Genetics of recurrent early-onset major depression (GenRED): significant linkage on chromosome 15q25-q26 after fine mapping with single nucleotide polymorphism markers. American Journal of Psychiatry 164, 259–264.CrossRefGoogle ScholarPubMed
Levy, ER, Powell, JF, Buckle, VJ, Hsu, YP, Breakefield, XO, Craig, IW (1989). Localization of human monoamine oxidase-A gene to Xp11.23-11.4 by in situ hybridization: implications for Norrie disease. Genomics 5, 368–370.CrossRefGoogle ScholarPubMed
Lewis, CM, Ng, MY, Butler, AW, Cohen-Woods, S, Uher, R, Pirlo, K, Weale, ME, Schosser, A, Paredes, UM, Rivera, M, Craddock, N, Owen, MJ, Jones, L, Jones, I, Korszun, A, Aitchison, KJ, Shi, J, Quinn, JP, Mackenzie, A, Vollenweider, P, Waeber, G, Heath, S, Lathrop, M, Muglia, P, Barnes, MR, Whittaker, JC, Tozzi, F, Holsboer, F, Preisig, M, Farmer, AE, Breen, G, Craig, IW, McGuffin, P (2010). Genome-wide association study of major recurrent depression in the U.K. population. American Journal of Psychiatry 167, 949–957.CrossRefGoogle ScholarPubMed
López-León, S, Janssens, AC, González-Zuloeta Ladd, AM, Del-Favero, J, Claes, SJ, Oostra, BA, van Duijn, CM (2008). Meta-analyses of genetic studies on major depressive disorder. Molecular Psychiatry 13, 772–785.CrossRefGoogle ScholarPubMed
Lotrich, FE, Pollock, BG (2004). Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatric Genetics 14, 121–129.CrossRefGoogle ScholarPubMed
Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium (2012). A mega-analysis of genome-wide association studies for major depressive disorder. Molecular Psychiatry. Published online 3 April 2012. doi:10.1038/mp.2012.21.Google Scholar
Manki, H, Kanba, S, Muramatsu, T, Higuchi, S, Suzuki, E, Matsushita, S, Ono, Y, Chiba, H, Shintani, F, Nakamura, M, Yagi, G, Asai, M (1996). Dopamine D2, D3 and D4 receptor and transporter gene polymorphisms and mood disorders. Journal of Affective Disorders 40, 7–13.CrossRefGoogle ScholarPubMed
Martin, J, Cleak, J, Willis-Owen, SA, Flint, J, Shifman, S (2007). Mapping regulatory variants for the serotonin transporter gene based on allelic expression imbalance. Molecular Psychiatry 12, 421–422.CrossRefGoogle ScholarPubMed
Maura, G, Thellung, S, Andrioli, GC, Ruelle, A, Raiteri, M (1993). Release-regulating serotonin 5-HT1D autoreceptors in human cerebral cortex. Journal of Neurochemistry 60, 1179–1182.CrossRefGoogle ScholarPubMed
McGuffin, P, Cohen, S, Knight, J (2007). Homing in on depression genes. American Journal of Psychiatry 164, 195–197.CrossRefGoogle Scholar
McGuffin, P, Katz, R, Watkins, S, Rutherford, J (1996). A hospital-based twin register of the heritability of DSM-IV unipolar depression. Archives of General Psychiatry 53, 129–136.CrossRefGoogle ScholarPubMed
McGuffin, P, Knight, J, Breen, G, Brewster, S, Boyd, PR, Craddock, N, Gill, M, Korszun, A, Maier, W, Middleton, L, Mors, O, Owen, MJ, Perry, J, Preisig, M, Reich, T, Rice, J, Rietschel, M, Jones, L, Sham, P, Farmer, AE (2005). Whole genome linkage scan of recurrent depressive disorder from the depression network study. Human Molecular Genetics 14, 3337–3345.CrossRefGoogle ScholarPubMed
McGuffin, P, Rijsdijk, F, Andrew, M, Sham, P, Katz, R, Cardno, A (2003). The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Archives of General Psychiatry 60, 497–502.CrossRefGoogle ScholarPubMed
McQuillin, A, Bass, N, Anjorin, A, Lawrence, J, Kandaswamy, R, Lydall, G, Moran, J, Sklar, P, Purcell, S, Gurling, H (2011). Analysis of genetic deletions and duplications in the University College London bipolar disorder case control sample. European Journal of Human Genetics 19, 588–592.CrossRefGoogle ScholarPubMed
Melmer, G, Sherrington, R, Mankoo, B, Kalsi, G, Curtis, D, Gurling, HM (1991). A cosmid clone for the 5HT1A receptor (HTR1A) reveals a TaqI RFLP that shows tight linkage to DNA loci D5S6, D5S39, and D5S76. Genomics 11, 767–769.CrossRefGoogle ScholarPubMed
Minov, C, Baghai, TC, Schule, C, Zwanzger, P, Schwarz, MJ, Zill, P, Rupprecht, R, Bondy, B (2001). Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression. Neuroscience Letters 303, 119–122.CrossRefGoogle ScholarPubMed
Miyake, A, Mochizuki, S, Takemoto, Y, Akuzawa, S (1995). Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species. Molecular Pharmacology 48, 407–416.Google ScholarPubMed
Modell, S, Lauer, CJ, Schreiber, W, Huber, J, Krieg, JC, Holsboer, F (1998). Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders. Neuropsychopharmacology 18, 253–262.CrossRefGoogle ScholarPubMed
Mueller, JC, Lohmussaar, E, Magi, R, Remm, M, Bettecken, T, Lichtner, P, Biskup, S, Illig, T, Pfeufer, A, Luedemann, J, Schreiber, S, Pramstaller, P, Pichler, I, Romeo, G, Gaddi, A, Testa, A, Wichmann, HE, Metspalu, A, Meitinger, T (2005). Linkage disequilibrium patterns and tagSNP transferability among European populations. American Journal of Human Genetics 76, 387–398.CrossRefGoogle ScholarPubMed
Muglia, P, Tozzi, F, Galwey, NW, Francks, C, Upmanyu, R, Kong, XQ, Antoniades, A, Domenici, E, Perry, J, Rothen, S, Vandeleur, CL, Mooser, V, Waeber, G, Vollenweider, P, Preisig, M, Lucae, S, Muller-Myhsok, B, Holsboer, F, Middleton, LT, Roses, AD (2010). Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Molecular Psychiatry 15, 589–601.CrossRefGoogle ScholarPubMed
Munafò, MR, Durrant, C, Lewis, G, Flint, J (2009). Gene × environment interactions at the serotonin transporter locus. Biological Psychiatry 65, 211–219.CrossRefGoogle ScholarPubMed
Murray, CJ, Lopez, AD (1997). Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349, 1436–1442.CrossRefGoogle ScholarPubMed
Nakamura, M, Ueno, S, Sano, A, Tanabe, H (2000). The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Molecular Psychiatry 5, 32–38.CrossRefGoogle ScholarPubMed
Nash, MW, Huezo-Diaz, P, Williamson, RJ, Sterne, A, Purcell, S, Hoda, F, Cherny, SS, Abecasis, GR, Prince, M, Gray, JA, Ball, D, Asherson, P, Mann, A, Goldberg, D, McGuffin, P, Farmer, A, Plomin, R, Craig, IW, Sham, PC (2004). Genome-wide linkage analysis of a composite index of neuroticism and mood-related scales in extreme selected sibships. Human Molecular Genetics 13, 2173–2182.CrossRefGoogle ScholarPubMed
Nurnberger, JI Jr., Foroud, T, Flury, L, Su, J, Meyer, ET, Hu, K, Crowe, R, Edenberg, H, Goate, A, Bierut, L, Reich, T, Schuckit, M, Reich, W (2001). Evidence for a locus on chromosome 1 that influences vulnerability to alcoholism and affective disorder. American Journal of Psychiatry 158, 718–724.CrossRefGoogle ScholarPubMed
Ogilvie, AD, Battersby, S, Bubb, VJ, Fink, G, Harmar, AJ, Goodwim, GM, Smith, CA (1996). Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 347, 731–733.CrossRefGoogle ScholarPubMed
Ohara, K, Nagai, M, Tani, K, Tsukamoto, T, Suzuki, Y (1998). Polymorphism in the promoter region of the alpha 2A adrenergic receptor gene and mood disorders. NeuroReport 9, 1291–1294.CrossRefGoogle ScholarPubMed
Ordway, GA, Schenk, J, Stockmeier, CA, May, W, Klimek, V (2003). Elevated agonist binding to alpha2-adrenoceptors in the locus coeruleus in major depression. Biological Psychiatry 53, 315–323.CrossRefGoogle ScholarPubMed
Oruc, L, Verheyen, GR, Furac, I, Ivezić, S, Jakovljević, M, Raeymaekers, P, Van Broeckhoven, C (1997). Positive association between the GABRA5 gene and unipolar recurrent major depression. Neuropsychobiology 36, 62–64.CrossRefGoogle ScholarPubMed
Owen, D, Du, L, Bakish, D, Lapierre, YD, Hrdina, PD (1999). Norepinephrine transporter gene polymorphism is not associated with susceptibility to major depression. Psychiatry Research 87, 1–5.CrossRefGoogle Scholar
Ozelius, L, Hsu, YP, Bruns, G, Powell, JF, Chen, S, Weyler, W, Utterback, M, Zucker, D, Haines, J, Trofatter, JA (1988). Human monoamine oxidase gene (MAOA): chromosome position (Xp21-p11) and DNA polymorphism. Genomics 3, 53–58.CrossRefGoogle ScholarPubMed
Panagiotou, OA, Ioannidis, JP; Genome-Wide Significant Project (2012). What should the genome-wide significance threshold be? Empirical replication of borderline genetic associations. International Journal of Epidemiology 41, 273–286.CrossRefGoogle ScholarPubMed
Pergadia, ML, Glowinski, AL, Wray, NR, Agrawal, A, Saccone, SF, Loukola, A, Broms, U, Korhonen, T, Penninx, BWJH, Grant, JD, Nelson, EC, Henders, AK, Schrage, AJ, Chou, Y, Keskitalo-Vuokko, K, Zhu, Q, Gordon, SD, Vink, JM, de Geus, EJC, MacGregor, S, Liu, JZ, Willemsen, G, Medland, SE, Boomsma, DI, Montgomery, GW, Rice, JP, Goate, AM, Heath, AC, Kaprio, J, Martin, NG, Madden, PAF (2011). A 3p26-3p25 genetic linkage finding for DSM-IV major depression in heavy smoking families. American Journal of Psychiatry 168, 848–852.CrossRefGoogle ScholarPubMed
Petronis, A (2001). Human morbid genetics revisited: relevance of epigenetics. Trends in Genetics 17, 142–146.CrossRefGoogle ScholarPubMed
Plotsky, PM, Owens, MJ, Nemeroff, CB (1998). Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatric Clinics of North America 21, 293–307.CrossRefGoogle ScholarPubMed
Porzgen, P, Bonisch, H, Bruss, M (1995). Molecular cloning and organization of the coding region of the human norepinephrine transporter gene. Biochemical and Biophysical Research Communications 215, 1145–1150.CrossRefGoogle ScholarPubMed
Priestley, JV, Cuello, AC (1982). Localisation studies on the interactions between neuropeptides and neurotransmitters involved in depression. Advances in Biochemical Psychopharmacology 31, 157–169.Google ScholarPubMed
Puig-Antich, J, Goetz, D, Davies, M, Kaplan, T, Davies, S, Ostrow, L, Asnis, L, Twomey, J, Iyengar, S, Ryan, ND (1989). A controlled family history study of prepubertal major depressive disorder. Archives of General Psychiatry 46, 406–418.CrossRefGoogle ScholarPubMed
Quested, DJ, Whale, R, Sharpley, AL, McGavin, CL, Crossland, N, Harrison, PJ, Cowen, PJ (1999). Allelic variation in the 5-HT2C receptor (HTR2C) and functional responses to the 5-HT2C receptor agonist, m-chlorophenylpiperazine. Psychopharmacology (Berlin) 144, 306–307.CrossRefGoogle Scholar
Rietschel, M, Mattheisen, M, Frank, J, Treutlein, J, Degenhardt, F, Breuer, R, Steffens, M, Mier, D, Esslinger, C, Walter, H, Kirsch, P, Erk, S, Schnell, K, Herms, S, Wichmann, HE, Schreiber, S, Jöckel, KH, Strohmaier, J, Roeske, D, Haenisch, B, Gross, M, Hoefels, S, Lucae, S, Binder, EB, Wienker, TF, Schulze, TG, Schmäl, C, Zimmer, A, Juraeva, D, Brors, B, Bettecken, T, Meyer-Lindenberg, A, Müller-Myhsok, B, Maier, W, Nöthen, MM, Cichon, S (2010). Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression. Biological Psychiatry 66, 578–585.CrossRefGoogle Scholar
Risch, N, Herrell, R, Lehner, T, Liang, KY, Eaves, L, Hoh, J, Griem, A, Kovacs, M, Ott, J, Merikangas, KR (2009). Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. Journal of the American Medical Association 301, 2462–2471.CrossRefGoogle ScholarPubMed
Rivera, M, Gutierrez, B, Molina, E, Torres-Gonzalez, F, Bellon, JA, Moreno-Kustner, B, King, M, Nazareth, I, Martinez-Gonzalez, LJ, Martinez-Espin, E, Munoz-Garcia, MM, Motrico, E, Martinez-Canavate, T, Lorente, JA, Luna, JD, Cervilla, JA (2009). High-activity variants of the uMAOA polymorphism increase the risk for depression in a large primary care sample. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 150B, 395–402.CrossRefGoogle Scholar
Rucker, JJ, Breen, G, Pinto, D, Pedroso, I, Lewis, CM, Cohen-Woods, S, Uher, R, Schosser, A, Rivera, M, Aitchison, KJ, Craddock, N, Owen, MJ, Jones, L, Jones, I, Korszun, A, Muglia, P, Barnes, MR, Preisig, M, Mors, O, Gill, M, Maier, W, Rice, J, Rietschel, M, Holsboer, F, Farmer, AE, Craig, IW, Scherer, SW, McGuffin, P (2011). Genome-wide association analysis of copy number variation in recurrent depressive disorder. Molecular Psychiatry. Published online: 1 November 2011. doi:10.1038/mp2011.144.Google ScholarPubMed
Ryu, SH, Lee, SH, Lee, HJ, Cha, JH, Ham, BJ, Han, CS, Choi, MJ, Lee, MS (2004). Association between norepinephrine transporter gene polymorphism and major depression. Neuropsychobiology 49, 174–177.CrossRefGoogle ScholarPubMed
Sapolsky, RM, Uno, H, Rebert, CS, Finch, CE (1990). Hippocampal damage associated with prolonged glucocorticoid exposure in primates. Journal of Neuroscience 10, 2897–2902.CrossRefGoogle ScholarPubMed
Sasaki, T, Hattori, M, Sakai, T, Kato, T, Kunugi, H, Hirose, T, Nanko, S (1998). The monoamine oxidase-A gene and major psychosis in Japanese subjects. Biological Psychiatry 44, 922–924.CrossRefGoogle ScholarPubMed
Schulze, TG, Muller, DJ, Krauss, H, Scherk, H, Ohlraun, S, Syagailo, YV, Windemuth, C, Neidt, H, Grassle, M, Papassotiropoulos, A, Heun, R, Nothen, MM, Maier, W, Lesch, KP, Rietschel, M (2000). Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. American Journal of Medical Genetics 96, 801–803.3.0.CO;2-4>CrossRefGoogle ScholarPubMed
Schumacher, J, Jamra, RA, Becker, T, Ohlraun, S, Klopp, N, Binder, EB, Schulze, TG, Deschner, M, Schmal, C, Hofels, S, Zobel, A, Illig, T, Propping, P, Holsboer, F, Rietschel, M, Nothen, MM, Cichon, S (2005). Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biological Psychiatry 58, 307–314.CrossRefGoogle ScholarPubMed
Shi, J, Potash, JB, Knowles, JA, Weissman, MM, Coryell, W, Scheftner, WA, Lawson, WB, DePaulo, Jr. JR, Gejman, PV, Sanders, AR, Johnson, JK, Adams, P, Chaudhury, S, Jancic, D, Evgrafov, O, Zvinyatskovskiy, A, Ertman, N, Gladis, M, Neimanas, K, Goodell, M, Hale, N, Ney, N, Verma, R, Mirel, D, Holmans, P, Levinson, DF (2011). Genome-wide association study of recurrent early-onset major depressive disorder. Molecular Psychiatry 16, 193–201.CrossRefGoogle ScholarPubMed
Shyn, SI, Shi, J, Kraft, JB, Potash, JB, Knowles, JA, Weissman, MM, Garriock, HA, Yokoyama, JS, McGrath, PJ, Peters, EJ, Scheftner, WA, Coryell, W, Lawson, WB, Jancic, D, Gejman, PV, Sanders, AR, Holmans, P, Slager, SL, Levinson, DF, Hamilton, SP (2011). Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies. Molecular Psychiatry 16, 202–215.CrossRefGoogle ScholarPubMed
Smith, MA, Makino, S, Kvetnansky, R, Post, RM (1995). Effects of stress on neurotrophic factor expression in the rat brain. Annals of the New York Academy of Sciences 771, 234–239.CrossRefGoogle ScholarPubMed
Sullivan, PF (2012). Don't give up on GWAS. Molecular Psychiatry 17, 2–3.CrossRefGoogle ScholarPubMed
Sullivan, PF, de Geus, EJ, Willemsen, G, James, MR, Smit, JH, Zandbelt, T, Arolt, V, Baune, BT, Blackwood, D, Cichon, S, Coventry, WL, Domschke, K, Farmer, A, Fava, M, Gordon, SD, He, Q, Heath, AC, Heutink, P, Holsboer, F, Hoogendijk, WJ, Hottenga, JJ, Hu, Y, Kohli, M, Lin, D, Lucae, S, Macintyre, DJ, Maier, W, McGhee, KA, McGuffin, P, Montgomery, GW, Muir, WJ, Nolen, WA, Nothen, MM, Perlis, RH, Pirlo, K, Posthuma, D, Rietschel, M, Rizzu, P, Schosser, A, Smit, AB, Smoller, JW, Tzeng, JY, van Dyck, R, Verhage, M, Zitman, FG, Martin, NG, Wray, NR, Boomsma, DI, Penninx, BW (2009). Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Molecular Psychiatry 14, 359–375.CrossRefGoogle ScholarPubMed
Sullivan, PF, Neale, MC, Kendler, KS (2000). Genetic epidemiology of major depression: review and meta-analysis. American Journal of Psychiatry 157, 1552–1562.CrossRefGoogle ScholarPubMed
Syagailo, YV, Stober, G, Grassle, M, Reimer, E, Knapp, M, Jungkunz, G, Okladnova, O, Meyer, J, Lesch, KP (2001). Association analysis of the functional monoamine oxidase A gene promoter polymorphism in psychiatric disorders. American Journal of Medical Genetics 105, 168–171.CrossRefGoogle ScholarPubMed
Tadic, A, Rujescu, D, Szegedi, A, Giegling, I, Singer, P, Moller, HJ, Dahmen, N (2003). Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 117, 1–6.CrossRefGoogle Scholar
Tan, EC, Chan, AO, Tan, CH, Mahendran, R, Wang, A, Chua, HC (2003). Case-control and linkage disequilibrium studies of the tryptophan hydroxylase gene polymorphisms and major depressive disorder. Psychiatric Genetics 13, 151–154.CrossRefGoogle ScholarPubMed
Terracciano, A, Tanaka, T, Sutin, AR, Sanna, S, Deiana, B, Lai, S, Uda, M, Schlessinger, D, Abecasis, GR, Ferrucci, L, Costa, PT Jr. (2010). Genome-wide association scan of trait depression. Biological Psychiatry 68, 811–817.CrossRefGoogle ScholarPubMed
Thapar, A, McGuffin, P (1994). A twin study of depressive symptoms in childhood. British Journal of Psychiatry 165, 259–265.CrossRefGoogle ScholarPubMed
Thomson, W, Barton, A, Ke, X, Eyre, S, Hinks, A, Bowes, J, Donn, R, Symmons, D, Hider, S, Bruce, IN, Wilson, AG, Marinou, I, Morgan, A, Emery, P, Carter, A, Steer, S, Hocking, L, Reid, DM, Wordsworth, P, Harrison, P, Strachan, D, Worthington, J (2007). Rheumatoid arthritis association at 6q23. Nature Genetics 39, 1431–1433.CrossRefGoogle ScholarPubMed
Tsai, SJ, Hong, CJ, Wang, YC (1999). Tryptophan hydroxylase gene polymorphism (A218C) and suicidal behaviors. NeuroReport 10, 3773–3775.CrossRefGoogle ScholarPubMed
Uher, R (2011). Genes, environment, and individual differences in responding to treatment for depression. Harvard Review of Psychiatry 19, 109–124.CrossRefGoogle ScholarPubMed
Verhagen, M, van der Meij, A, van Deurzen, PA, Janzing, JG, Arias-Vasquez, A, Buitelaar, JK, Franke, B (2010). Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Molecular Psychiatry 15, 260–271.CrossRefGoogle ScholarPubMed
Verma, R, Holmans, P, Knowles, JA, Grover, D, Evgrafov, OV, Crowe, RR, Scheftner, WA, Weissman, MM, DePaulo, Jr. JR, Potash, JB, Levinson, DF (2008). Linkage disequilibrium mapping of a chromosome 15q25-26 major depression linkage region and sequencing of NTRK3. Biological Psychiatry 63, 1185–1189.CrossRefGoogle ScholarPubMed
Viikki, M, Kampman, O, Illi, A, Setala-Soikkeli, E, Anttila, S, Huuhka, M, Nuolivirta, T, Poutanen, O, Mononen, N, Lehtimaki, T, Leinonen, E (2010). TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response. Neuroscience Letters 468, 80–84.CrossRefGoogle ScholarPubMed
Walsh, T, McClellan, JM, McCarthy, SE, Addington, AM, Pierce, SB, Cooper, GM, Nord, AS, Kusenda, M, Malhotra, D, Bhandari, A, Stray, SM, Rippey, CF, Roccanova, P, Makarov, V, Lakshmi, B, Findling, RL, Sikich, L, Stromberg, T, Merriman, B, Gogtay, N, Butler, P, Eckstrand, K, Noory, L, Gochman, P, Long, R, Chen, Z, Davis, S, Baker, C, Eichler, EE, Meltzer, PS, Nelson, SF, Singleton, AB, Lee, MK, Rapoport, JL, King, MC, Sebat, J (2008). Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320, 539–543.CrossRefGoogle ScholarPubMed
Walther, DJ, Bader, M (2003). A unique central tryptophan hydroxylase isoform. Biochemical Pharmacology 66, 1673–1680.CrossRefGoogle ScholarPubMed
Wang, HC, Yeh, TL, Chang, HH, Gean, PW, Chi, MH, Yang, YK, Lu, RB, Chen, PS (2011). TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients. Psychopharmacology (Berlin) 213, 773–779.CrossRefGoogle Scholar
Weissman, MM, Fendrich, M, Warner, V, Wickramaratne, P (1992). Incidence of psychiatric disorder in offspring at high and low risk for depression. Journal of the American Academy of Child and Adolescent Psychiatry 31, 640–648.CrossRefGoogle ScholarPubMed
Weissman, MM, Gammon, GD, John, K, Merikangas, KR, Warner, V, Prusoff, BA, Sholomskas, D (1987). Children of depressed parents. Increased psychopathology and early onset of major depression. Archives of General Psychiatry 44, 847–853.CrossRefGoogle ScholarPubMed
Wendland, JR, Martin, BJ, Kruse, MR, Lesch, KP, Murphy, DL (2006). Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Molecular Psychiatry 11, 224–226.CrossRefGoogle ScholarPubMed
Wilhelm, K, Mitchell, PB, Niven, H, Finch, A, Wedgwood, L, Scimone, A, Blair, IP, Parker, G, Schofield, PR (2006). Life events, first depression onset and the serotonin transporter gene. British Journal of Psychiatry 188, 210–215.CrossRefGoogle ScholarPubMed
Willis-Owen, SA, Turri, MG, Munafo, MR, Surtees, PG, Wainwright, NW, Brixey, RD, Flint, J (2005). The serotonin transporter length polymorphism, neuroticism, and depression: a comprehensive assessment of association. Biological Psychiatry 58, 451–456.CrossRefGoogle ScholarPubMed
Wray, NR, Pergadia, ML, Blackwood, DH, Penninx, BW, Gordon, SD, Nyholt, DR, Ripke, S, MacIntyre, DJ, McGhee, KA, Maclean, AW, Smit, JH, Hottenga, JJ, Willemsen, G, Middeldorp, CM, de Geus, EJ, Lewis, CM, McGuffin, P, Hickie, IB, van den Oord, EJ, Liu, JZ, Macgregor, S, McEvoy, BP, Byrne, EM, Medland, SE, Statham, DJ, Henders, AK, Heath, AC, Montgomery, GW, Martin, NG, Boomsma, DI, Madden, PA, Sullivan, PF (2012). Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. Molecular Psychiatry 17, 36–48.CrossRefGoogle ScholarPubMed
Yamada, K, Hattori, E, Iwayama, Y, Ohnishi, T, Ohba, H, Toyota, T, Takao, H, Minabe, Y, Nakatani, N, Higuchi, T, Detera-Wadleigh, SD, Yoshikawa, T (2006). Distinguishable haplotype blocks in the HTR3A and HTR3B region in the Japanese reveal evidence of association of HTR3B with female major depression. Biological Psychiatry 60, 192–201.CrossRefGoogle ScholarPubMed
Youdim, MB, Edmondson, D, Tipton, KF (2006). The therapeutic potential of monoamine oxidase inhibitors. Nature Reviews Neuroscience 7, 295–309.CrossRefGoogle ScholarPubMed
Yu, YW, Chen, TJ, Wang, YC, Liou, YJ, Hong, CJ, Tsai, SJ (2003). Association analysis for neuronal nitric oxide synthase gene polymorphism with major depression and fluoxetine response. Neuropsychobiology 47, 137–140.CrossRefGoogle ScholarPubMed
Zeggini, E, Weedon, MN, Lindgren, CM, Frayling, TM, Elliott, KS, Lango, H, Timpson, NJ, Perry, JR, Rayner, NW, Freathy, RM, Barrett, JC, Shields, B, Morris, AP, Ellard, S, Groves, CJ, Harries, LW, Marchini, JL, Owen, KR, Knight, B, Cardon, LR, Walker, M, Hitman, GA, Morris, AD, Doney, AS, McCarthy, MI, Hattersley, AT (2007). Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316, 1336–1341.CrossRefGoogle ScholarPubMed
Zhang, D, Cheng, L, Qian, Y, Alliey-Rodriguez, N, Kelsoe, JR, Greenwood, T, Nievergelt, C, Barrett, TB, McKinney, R, Schork, N, Smith, EN, Bloss, C, Nurnberger, J, Edenberg, HJ, Foroud, T, Sheftner, W, Lawson, WB, Nwulia, EA, Hipolito, M, Coyell, W, Rice, J, Byerley, W, McMahon, F, Schulze, TG, Berrettini, W, Potash, JB, Belmonte, PL, Zandi, PP, McInnes, MG, Zöllner, S, Craig, D, Szelinger, S, Koller, D, Christian, SL, Liu, C, Gershon, ES (2009). Singleton deletions throughout the genome increase risk of bipolar disorder. Molecular Psychiatry 14, 376–380.CrossRefGoogle ScholarPubMed
Zhang, J, Chen, Y, Zhang, K, Yang, H, Sun, Y, Fang, Y, Shen, Y, Xu, Q (2010). A cis-phase interaction study of genetic variants within the MAOA gene in major depressive disorder. Biological Psychiatry 68, 795–800.CrossRefGoogle ScholarPubMed
Zhang, X, Gainetdinov, RR, Beaulieu, JM, Sotnikova, TD, Burch, LH, Williams, RB, Schwartz, DA, Krishnan, KR, Caron, MG (2005). Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11–16.CrossRefGoogle ScholarPubMed
Zill, P, Baghai, TC, Engel, R, Zwanzger, P, Schule, C, Minov, C, Behrens, S, Bottlender, R, Jager, M, Rupprecht, R, Moller, HJ, Ackenheil, M, Bondy, B (2003). Beta-1-adrenergic receptor gene in major depression: influence on antidepressant treatment response. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 120, 85–89.CrossRefGoogle Scholar
Zubenko, GS, Hughes, HB 3rd, Maher, BS, Stiffler, JS, Zubenko, WN, Marazita, ML (2002). Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression. American Journal of Medical Genetics 114, 980–987.CrossRefGoogle ScholarPubMed
Zubenko, GS, Maher, B, Hughes, HB 3rd, Zubenko, WN, Stiffler, JS, Kaplan, BB, Marazita, ML (2003). Genome-wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent, early-onset, major depression. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 123, 1–18.CrossRefGoogle Scholar
Supplementary material: File

Cohen-Woods supplementary material

Appendix

Download Cohen-Woods supplementary material(File)
File 295.4 KB